Medical technology company Sectra (STO:SECT-B) announced on Thursday that a US health system will expand its enterprise imaging solution with digital pathology.

This addition aims to enhance diagnostic efficiency by enabling pathologists to review and collaborate on cases more effectively. A unified system for storing and viewing images across medical specialties supports integrated diagnostics, crucial for efficient cancer care. Since 2018, the health system has utilized Sectra's enterprise imaging solution for radiology, mammography and orthopaedics. The digital pathology module facilitates seamless AI integration and instant, remote access to digital tissue images, replacing physical glass slides.

Signed in January 2025, the contract strengthens the system's scalability, allowing healthcare providers to expand without additional infrastructure investments. Sectra's enterprise imaging solution improves outcomes while reducing operational costs.